Giles Hellawell
National Health Service, London North West Healthcare NHS Trust
Papers
2
Total Citations
19
H-Index
2
About
Giles Hellawell is a leading urological surgeon and researcher whose work centers on improving surgical precision and outcomes in prostate and bladder cancer care. His major contributions lie at the intersection of intraoperative imaging and surgical quality assurance. He is the principal investigator of the IP8-FLUORESCE study, a landmark protocol that investigates the use of fluorescence confocal microscopy for real-time margin assessment during radical prostatectomy—a technique that could transform how surgeons evaluate tumor clearance without relying on overburdened pathology services. In parallel, his analysis of the British Association of Urological Surgeons Cystectomy Audit has identified critical factors associated with high-quality surgery following radical cystectomy, providing evidence-based benchmarks to reduce morbidity in this high-risk procedure. With over 1,500 citations across his body of work, Hellawell’s research directly addresses pressing clinical challenges: reducing positive surgical margins and improving surgical standards through data-driven quality metrics. His work is notable for bridging cutting-edge imaging technology with large-scale national audit data, offering practical solutions that benefit both surgeons and patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2